rs143987857

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. BS1BS2PP3_Moderate

This summary comes from the ClinGen Evidence Repository: This pathogenicity assessment is relevant only for malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions.This sequence variant predicts a substitution of arginine with histidine at codon 3539 of the RYR1 protein, p.(Arg3539His). The maximum allele frequency for this variant among the six major gnomAD populations is NFE: 0.00305, this is considered to be more common than expected for a pathogenic variant causing autosomal dominantly inherited MHS, BS1. This variant has been reported in 10 unrelated individuals who have a personal or family history of a malignant hyperthermia reaction, all of these individuals had a positive in vitro contracture test (IVCT) or caffeine halothane contracture test (CHCT) result (if the proband was unavailable for testing, a positive diagnostic test result in a mutation-positive relative was counted) (PMID:30236257; PMID:23460944; PMID:23558838; PMID:24433488; PMID:25960145), however, the high MAF in the NFE population precludes the use of PS4. This variant has been identified in multiple individuals with negative IVCT/CHCT results, BS2 (PMID:18253926, PMID:22473935). No functional studies were identified for this variant. This variant does not reside in a hotspot for pathogenic variants that contribute to MHS. A REVEL score >0.85 (0.877) supports a pathogenic status for this variant, PP3_Moderate. Based on using Bayes to combine criteria this variant is assessed as Likely Benign, (PMID:29300386). Criteria implemented: PP3_Moderate, BS1, BS2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA023847/MONDO:0018493/012

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0022 ( 7 hom. )

Consequence

RYR1
NM_000540.3 missense

Scores

9
7
1

Clinical Significance

Likely benign reviewed by expert panel U:15B:12O:2

Conservation

PhyloP100: 9.76

Publications

22 publications found
Variant links:
Genes affected
RYR1 (HGNC:10483): (ryanodine receptor 1) This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
RYR1 Gene-Disease associations (from GenCC):
  • malignant hyperthermia, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, ClinGen
  • RYR1-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • congenital multicore myopathy with external ophthalmoplegia
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • central core myopathy
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • King-Denborough syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant hyperthermia of anesthesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • benign Samaritan congenital myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital myopathy with myasthenic-like onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PP3
For more information check the summary or visit ClinGen Evidence Repository.
BS1
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000540.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
NM_000540.3
MANE Select
c.10616G>Ap.Arg3539His
missense
Exon 71 of 106NP_000531.2P21817-1
RYR1
NM_001042723.2
c.10601G>Ap.Arg3534His
missense
Exon 70 of 105NP_001036188.1P21817-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RYR1
ENST00000359596.8
TSL:5 MANE Select
c.10616G>Ap.Arg3539His
missense
Exon 71 of 106ENSP00000352608.2P21817-1
RYR1
ENST00000355481.8
TSL:1
c.10601G>Ap.Arg3534His
missense
Exon 70 of 105ENSP00000347667.3P21817-2
RYR1
ENST00000594335.6
TSL:1
n.*1344G>A
non_coding_transcript_exon
Exon 69 of 103ENSP00000470927.2M0R014

Frequencies

GnomAD3 genomes
AF:
0.00165
AC:
251
AN:
151956
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00306
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00155
AC:
389
AN:
250486
AF XY:
0.00174
show subpopulations
Gnomad AFR exome
AF:
0.000495
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.00293
Gnomad OTH exome
AF:
0.000817
GnomAD4 exome
AF:
0.00224
AC:
3271
AN:
1461700
Hom.:
7
Cov.:
32
AF XY:
0.00215
AC XY:
1567
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.000388
AC:
13
AN:
33476
American (AMR)
AF:
0.000179
AC:
8
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000522
AC:
45
AN:
86246
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53384
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5752
European-Non Finnish (NFE)
AF:
0.00273
AC:
3038
AN:
1111936
Other (OTH)
AF:
0.00194
AC:
117
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
192
384
577
769
961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
250
AN:
152074
Hom.:
0
Cov.:
30
AF XY:
0.00164
AC XY:
122
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.000555
AC:
23
AN:
41468
American (AMR)
AF:
0.000262
AC:
4
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00306
AC:
208
AN:
67976
Other (OTH)
AF:
0.00142
AC:
3
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00220
Hom.:
1
Bravo
AF:
0.00144
TwinsUK
AF:
0.00189
AC:
7
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00173
AC:
210
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00245
EpiControl
AF:
0.00213

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
10
5
not provided (16)
-
1
3
Malignant hyperthermia, susceptibility to, 1 (4)
-
3
1
not specified (4)
-
-
1
Central core myopathy (1)
-
-
1
Malignant hyperthermia of anesthesia (1)
-
-
1
RYR1-related disorder (2)
-
1
-
RYR1-related myopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.59
BayesDel_addAF
Uncertain
0.047
T
BayesDel_noAF
Pathogenic
0.30
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.82
D
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.38
D
MetaRNN
Benign
0.090
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.3
M
PhyloP100
9.8
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-4.4
D
REVEL
Pathogenic
0.88
Sift
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.71
MVP
0.98
MPC
0.38
ClinPred
0.059
T
GERP RS
3.1
Varity_R
0.41
gMVP
0.50
Mutation Taster
=64/36
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143987857; hg19: chr19-39016132; COSMIC: COSV62094702; COSMIC: COSV62094702; API